Skip to main content
. 2022 Dec 2;15:7077–7093. doi: 10.2147/IDR.S388568

Table 1.

The Clinical Characteristic of All Enrolled Patients

Total Active Tuberculosis Non-Active Tuberculosis p value
n=1193 n=114 n=1079
Male 747 (62.6%) 85 (74.6%) 662 (61.4%) 0.006*
Age (years) 0.026*
<65 700 (58.7%) 78 (68.4%) 622 (57.6%)
≥65 493 (41.3%) 36 (31.6%) 457 (42.4%)
Obsolescent tuberculosis 108 (9.1%) 17 (14.9%) 91 (8.4%) 0.022*
Contact history with tuberculosis patients 3 (0.3%) 2 (1.8%) 1 (0.1%) 0.025 #
Smoking history 469 (39.3%) 57 (50%) 412 (38.2%) 0.014*
Gastric surgery history 31 (2.6%) 4 (3.5%) 27 (2.5%) 0.739
Pneumoconiosis 2 (0.2%) 1 (0.9%) 1 (0.1%) 0.182 #
HIV 8 (0.7%) 1 (0.9%) 7 (0.6%) 0.553 #
Cirrhosis 7 (0.6%) 0 (0%) 7 (0.6%) 0.828
Hypoproteinemia 114 (9.6%) 37 (9.7%) 77 (9.6%) 0.920
Hypertension 394 (33%) 21 (18.4%) 373 (34.6%) <0.001*
Diabetes 194 (16.3%) 24 (21.1%) 170 (15.8%) 0.145
Cardiovascular and cerebrovascular diseases 148 (12.4%) 11 (9.6%) 137 (12.7%) 0.348
Renal insufficiency 41 (3.4%) 3 (2.6%) 38 (3.5%) 0.821
Autoimmune diseases 79 (6.6%) 6 (5.3%) 73 (6.8%) 0.540
Systemic corticosteroid usage 35 (2.9%) 5 (4.4%) 30 (2.8%) 0.500
Immunosuppressants usage 22 (1.8%) 2 (1.8%) 20 (1.9%) 1.000
Cancer 441 (37%) 8 (7%) 433 (40.1%) <0.001*
Radiotherapy and chemotherapy history 62 (5.2%) 4 (3.5%) 58 (5.4%) 0.393
Hepatitis 54 (4.5%) 7 (6.1%) 47 (4.4%) 0.383
Venous thromboembolic diseases 19 (1.6%) 0 (0%) 19 (1.8%) 0.301
Asthma 36 (3%) 1 (0.9%) 35 (3.2%) 0.264
COPD 134 (11.2%) 4 (3.5%) 130 (12%) 0.006*
Pulmonary sarcoidosis 20 (1.7%) 0 (0%) 20 (1.9%) 0.279

Notes: Numbers of patients (constituent ratio) were shown in the table The result of χ2 test between active tuberculosis and non-active tuberculosis groups were shown as p values. #Fisher’s exact probability method was used. *p values<0.05 were considered to be statistically significant.